NCT06006065

Brief Summary

A randomized, controlled, and evaluator-blinded trial will be carried out to investigate the effects of 8 weeks of upper limb somatosensory discrimination therapy compared to an equal dose of motor therapy on sensorimotor outcomes in children and adolescents with spastic unilateral cerebral palsy aged 7 to 15 years old. Additionally, the potential role of clinical and neurological baseline characteristics on treatment response will be explored, including the extent of the brain lesion, age and baseline somatosensory function. The researchers primarily expect that the bimanual performance will improve equally in children and adolescents from both intervention groups, as measured immediately after the intervention has ended. The researchers hypothesize, however, that there will be a better retention effect in children and adolescents that received somatosensory discrimination therapy, resulting in differences between both groups in bimanual performance as measured at 6-months follow-up. The researchers further expect larger improvements in somatosensory function for children and adolescents in the somatosensory discrimination group and this both immediately after the intervention and at 6-month follow-up.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Dec 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 23, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

December 9, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

12 months

First QC Date

August 8, 2023

Last Update Submit

February 6, 2024

Conditions

Keywords

Upper extremity[MeSH]Physiotherapy[MeSH]Occupational therapy[MeSH]Somatosensory discrimination therapyUpper limb motor therapyRandomized controlled trial[MeSH]Child[MeSH]Adolescent[MeSH]Somatosensation[MeSH]Bimanual performanceGoal performanceRobotics[MeSH]Neuroimaging[MeSH]

Outcome Measures

Primary Outcomes (1)

  • Bimanual performance/functional hand use

    The Assisting Hand Assessment (AHA) and Adolescent Assessment Hand Assessment (Ad-AHA) evaluate the spontaneous use of the more impaired upper limb during bimanual activities. For these assessments a semi-structured play session with standardized toys and materials, that require the use of both hands, is performed and video-recorded. Subsequently, 20 items are scored on a four-point Likert scale ranging from 1 ('does not do') to 4 ('effective use') and a logit-based total score in AHA unit is calculated, ranging from 0 to 100 AHA units. A highers score represents better bimanual performance. The AHA and Ad-AHA have shown to be a reliable and valid assessment for children and adolescents with unilateral cerebral palsy. Depending on the age of the participants, the AHA or Ad-AHA will be selected at each time point.

    Baseline, post-intervention (within one week) and after 6 months follow-up

Secondary Outcomes (14)

  • Functional hand use

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • Bimanual coordination

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • Bimanual coordination

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • Proprioception - Kinarm Exoskeleton: 'Perceptual boundary task'

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • Proprioception - Kinarm Exoskeleton: 'Contralateral position matching task'

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • +9 more secondary outcomes

Other Outcomes (4)

  • Attentional functioning

    Baseline, post-intervention (within one week) and after 6 months follow-up

  • Structural Magnetic Resonance Imaging (MRI) - semi-quantitative MRI scale

    Baseline

  • Structural Magnetic Resonance Imaging (MRI) - MRI classification system

    Baseline

  • +1 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Upper limb somatosensory discrimination therapy (Sense for Kids therapy)

Behavioral: Upper limb somatosensory discrimination therapy

Active control group

ACTIVE COMPARATOR

Upper limb motor therapy

Behavioral: Upper limb motor therapy

Interventions

Participants will receive three 45 minute sessions of upper limb somatosensory discrimination therapy per week for a period of 8 weeks. Each session includes 30 minutes of component-based training, including graded practice of three components of somatosensation (i.e., tactile object recognition, texture discrimination and proprioception). Next, 15 minutes of occupation-based practice will be completed to enhance transfer to a functional context. This includes repetitive and structured practice of self-chosen activities of daily living, while attention is designated to the somatosensory aspects necessary for successful task completion (e.g., identification of button based on touch).

Also known as: Sense for Kids therapy
Intervention group

Participants in the control group will receive an equal amount of motor training, including 30 minutes of unimanual motor tasks and 15 minutes of bimanual goal directed training. The unimanual motor tasks will be selected based on the main difficulties of the child (e.g., grip strength, supination). Bimanual goal directed training includes whole task practice of self-chosen activities of daily living. All therapy sessions will be performed under supervision of a trained physical and/or occupational therapist. Therapy adherence and progression will be closely monitored by the therapist.

Active control group

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Congenital or acquired, predominantly spastic unilateral cerebral palsy;
  • Aged 7 to 15 years;
  • Minimal ability to actively grasp and hold an object (modified House Functional Classification System ≥4);
  • Having a confirmed impairment in tactile function as objectified using a clinical assessment battery containing assessments of tactile registration and tactile perception; and
  • Sufficient cooperation to comprehend and complete the test and therapy procedures;

You may not qualify if:

  • Botulinum toxin-A injections six months prior to testing;
  • A history of upper limb surgery one year prior to testing;
  • Severe comorbidities hindering test assessments (e.g., severe cognitive problems); and
  • Inability to communicate in Dutch.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

Related Publications (1)

  • Kleeren L, Mailleux L, McLean B, Elliott C, Dequeker G, Van Campenhout A, de Xivry JO, Verheyden G, Ortibus E, Klingels K, Feys H. Does somatosensory discrimination therapy alter sensorimotor upper limb function differently compared to motor therapy in children and adolescents with unilateral cerebral palsy: study protocol for a randomized controlled trial. Trials. 2024 Feb 26;25(1):147. doi: 10.1186/s13063-024-07967-4.

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Sensation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Nervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Hilde Feys, MSc, PhD

    KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lisa Mailleux, MSc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessments of sensorimotor upper limb function at all three time points will be performed by a blinded assessor who is not involved in the conception of the study or the provision of therapy to the participants. Assessments that were video-recorded (Assisting Hand Assessment and Goal Attainment Scaling) will be scored afterwards by another evaluator who will be blinded to group allocation and time point of assessment. Since the robotic measurements and three-dimensional motion analysis are fully automated, these assessments will be performed by a physiotherapist not blinded to group allocation. Participants and parents will be blinded to the study hypotheses. The treating therapists will not be blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomization will be performed by an independent person who is not involved in the selection procedure and will not have access to any additional clinical information about the participants.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Full professor at the Faculty of Movement and Rehabilitation Sciences; Vice rector of Diversity Policy and Student Affairs, also responsible for Sports, Health and Well-being

Study Record Dates

First Submitted

August 8, 2023

First Posted

August 23, 2023

Study Start

December 9, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

February 7, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations